Table 4 Chi-square analysis and Spearson relative analysis among the expression of c-MET, p-MET, e2f-1 and Ki-67
From: Expressions and clinical significances of c-MET, p-MET and E2f-1 in human gastric carcinoma
Parameters | c-MET expression (n/%) | ||||||
|---|---|---|---|---|---|---|---|
Positive | Negative | χ2value | P 1 value* | r value | P 2 value# | ||
c-MET | Positive | 80/66.1 | |||||
Negative | 41/33.9 | ||||||
P-MET | Positive | 70/57.9 | 2/1.7 | 28.765 | 0.001 | 0.635 | 0.001 |
Negative | 10/8.3 | 39/32.2 | |||||
e2f-1 | Positive | 33/27.3 | 14/11.6 | 0.766 | 0.290 | 0.142 | 0.395 |
Negative | 47/38.8 | 27/22.3 | |||||
Ki-67 | Positive | 70/57.8 | 18/14.9 | 28.262 | <0.001 | 0.621 | <0.001 |
Negative | 10/8.3 | 23/19.0 | |||||
p-MET expression (n/%) | |||||||
e2f-1 | Positive | 29/24.0 | 18/14.9 | 0.811 | 0.308 | 0.195 | 0.518 |
Negative | 43/35.5 | 31/25.6 | |||||
Ki-67 | Positive | 66/54.5 | 22/18.2 | 29.233 | <0.001 | 0.667 | <0.001 |
Negative | 6/5.0 | 27/22.3 | |||||
e2f-1 expression (n/%) | |||||||
Ki-67 | Positive | 35/28.9 | 53/43.8 | 0.021 | 0.858 | -0.018 | 0.861 |
Negative | 12/9.9 | 21/17.4 | |||||